Randy L. Johnson
Molecular Biology · 2010–2014
A researcher in the Science corpus: 5 papers; trusts 19 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 94 citations into it; #11,998 of 17,773 by trust here, #7,842 by citations
- Cell Biology — 83 citations into it; #254 of 2,073 by trust here, #336 by citations
- Oncology — 27 citations into it
Whom Randy L. Johnson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Bin Zhao
- C. Scheel
- Jixin Dong
- Shian Wu
- Q. Lei
- Li Li
- M. Aragona
- Madhuri Kango-Singh
- Duojia Pan
- R. Weinberg
Who trusts Randy L. Johnson overall
Papers from Randy L. Johnson's perspective
Ordered by how strongly the researchers Randy L. Johnson trusts endorse each paper. Same corpus, a different order for every researcher.
- Elucidation of a universal size-control mechanism in Drosophila and mammals. (Cell)
- Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon (Proceedings of the National Academy of Sciences of the United States of America)
- salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. (Cell)
- The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. (Cell)
- YAP1 increases organ size and expands undifferentiated progenitor cells. (Current Biology)
- The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. (Cell)
- Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway (Nature Cell Biology)
- The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis (Nature Cell Biology)
- Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. (Cell)
- The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. (Developmental Cell)
Their papers
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver (2010) — 748 citations
- Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size (2011) — 1,104 citations
- Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer (2014) — 668 citations
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (2013) — 871 citations
- Hippo signaling: growth control and beyond (2011) — 1,073 citations